9005 Westside Pkwy.
Alpharetta, GA, 30004 United States
Inhibitex aims to inhibit deadly viruses. The company is pursuing the development of small-molecule antiviral compounds targeting diseases including herpes zoster (shingles), HIV, hepatitis C, and cytomegalovirus (CMV). The company was previously focused on developing anti-infectives for deadly Staphylococcus and other hospital-associated infections. Inhibitex continues to work on its vaccine development program targeting staph infections with